Cardiff Oncology, Inc.(CRDF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CRDF Cardiff Oncology, Inc.

Trading 10-22 14:49:07 EDT

0.9244

-0.0146

-1.55%

High0.9738	Low0.9200	Vol176.83K
Open0.9300	D1 Closing0.9390	Amplitude5.73%
Mkt Cap71.80M	Tradable Cap69.55M	Total Shares77.67M
T/O168.32K	T/O Rate0.24%	Tradable Shares75.24M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CRDF","market":"US","secType":"STK","nameCN":"Cardiff Oncology, Inc.","latestPrice":0.9244,"timestamp":1792694663663,"preClose":0.939,"halted":0,"volume":176826,"delay":0,"changeRate":-0.015548455804046802,"floatShares":75235000,"shares":77673000,"eps":-0.591396,"marketStatus":"Trading","change":-0.0146,"latestTime":"10-22 14:49:07 EDT","open":0.93,"high":0.9738,"low":0.92,"amount":168322.5083904,"amplitude":0.057295,"askPrice":0.9358,"askSize":84,"bidPrice":0.9238,"bidSize":1110,"shortable":3,"etf":0,"ttmEps":-0.591396,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1792699200000},"marketStatusCode":2,"adr":0,"listingDate":1059624000000,"exchange":"NASDAQ","adjPreClose":0.939,"preHourTrading":{"tag":"盘前","latestPrice":0.932,"preClose":0.939,"latestTime":"09:28 EDT","volume":30651,"amount":30011.6385306,"timestamp":1792675731848,"change":-0.007,"changeRate":-0.007455,"amplitude":0.127796},"postHourTrading":{"tag":"盘后","latestPrice":1.05,"preClose":0.939,"latestTime":"19:57 EDT","volume":98488,"amount":98165.8696,"timestamp":1792627022191,"change":0.111,"changeRate":0.118211,"amplitude":0.173056},"volumeRatio":0.443815,"impliedVol":3.3794,"impliedVolPercentile":0.9323},"requestUrl":"/m/hq/s/CRDF","defaultTab":"news","newsList":[{"id":"2677482604","title":"Cardiff Oncology Gets FDA Orphan Drug Designation for Onvansertib in CMML","url":"https://stock-news.laohu8.com/highlight/detail?id=2677482604","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677482604?lang=en_us&edition=fundamental","pubTime":"2026-10-22 04:06","pubTimestamp":1792613198,"startTime":"0","endTime":"0","summary":"Cardiff Oncology Gets FDA Orphan Drug Designation for Onvansertib in CMMLFDA granted orphan drug designation to Cardiff Oncology's onvansertib for chronic myelomonocytic leukemia.The designation may p","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL4MwFZp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","CRDF","NDAQ","BK4112","LU2210149790.SGD","LU2095319765.USD","BCDF","SG9999014039.USD","IE00BKPKM429.USD","SG9999014021.USD","IE00BQXX3D17.EUR","SG9999014013.SGD","IE00BN0W2W23.USD","BK4588","IE00BQXX3C00.GBP","IE00BQXX3F31.USD","BK4585","LU0314104364.USD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","BK4139","LU2210150020.SGD","IE00BGHQF748.EUR","SG9999014005.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677602970","title":"Cardiff Oncology - Onvansertib Being Evaluated in Phase 1 Study for Relapsed/Refractory Cmml","url":"https://stock-news.laohu8.com/highlight/detail?id=2677602970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677602970?lang=en_us&edition=fundamental","pubTime":"2026-10-22 04:05","pubTimestamp":1792613100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nTUA15WYGT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRDF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677460243","title":"Cardiff Oncology - Onvansertib Showed Preliminary Efficacy in 40% of Myeloproliferative Cmml Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2677460243","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677460243?lang=en_us&edition=fundamental","pubTime":"2026-10-22 04:05","pubTimestamp":1792613100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nTUA15WYGT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677360496","title":"Cardiff Oncology Receives FDA Orphan Drug Designation for Onvansertib in Chronic Myelomonocytic Leukemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2677360496","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677360496?lang=en_us&edition=fundamental","pubTime":"2026-10-22 04:05","pubTimestamp":1792613100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nTUA15WYGT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRDF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677606037","title":"Cardiff Oncology treatment of chronic myelomonocytic leukemia gets orphan status","url":"https://stock-news.laohu8.com/highlight/detail?id=2677606037","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677606037?lang=en_us&edition=fundamental","pubTime":"2026-10-22 02:00","pubTimestamp":1792605615,"startTime":"0","endTime":"0","summary":"Cardiff Oncology’s (CRDF) onvansertib was granted FDA orphan designation as a treatment of chronic myelomonocytic leukemia, according to a post to ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cardiff-oncology-treatment-of-chronic-myelomonocytic-leukemia-gets-orphan-status-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cardiff-oncology-treatment-of-chronic-myelomonocytic-leukemia-gets-orphan-status-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRDF","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667962115","title":"Cardiff Oncology Shares Rise After Upgrade From HC Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2667962115","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667962115?lang=en_us&edition=fundamental","pubTime":"2026-09-16 02:55","pubTimestamp":1789498546,"startTime":"0","endTime":"0","summary":"Cardiff Oncology  shares were up more than 3% in afternoon trading on Tuesday after HC Wainwright upgraded the company's stock to buy from neutral.Trading volume stood at more than 2.7 million shares against a daily average of about 1.2 million.Price: 1.35, Change: +0.04, Percent Change: +3.05","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CRDF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667649513","title":"Cardiff Oncology Price Target Announced at $9.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2667649513","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667649513?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:38","pubTimestamp":1789468680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRDF/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667646088","title":"HC Wainwright Upgrades Cardiff Oncology to Buy From Neutral, Price Target is $9","url":"https://stock-news.laohu8.com/highlight/detail?id=2667646088","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667646088?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:32","pubTimestamp":1789468325,"startTime":"0","endTime":"0","summary":"Cardiff Oncology (CRDF) has an average rating of hold and mean price target of $4.17, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ba","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CRDF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667461006","title":"Cardiff Oncology, Inc. : H.c. Wainwright Raises to Buy from Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2667461006","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667461006?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:26","pubTimestamp":1789467995,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN45702M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667646970","title":"Cardiff Oncology upgraded to Buy from Neutral at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2667646970","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667646970?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:10","pubTimestamp":1789467035,"startTime":"0","endTime":"0","summary":"H.C. Wainwright upgraded Cardiff Oncology (CRDF) to Buy from Neutral with a $9 price target The company reached a settlement with Nerviano and amen...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cardiff-oncology-upgraded-to-buy-from-neutral-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cardiff-oncology-upgraded-to-buy-from-neutral-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667261429","title":"U.S. Research Roundup-Eli Lilly, McDonald's, Welltower","url":"https://stock-news.laohu8.com/highlight/detail?id=2667261429","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667261429?lang=en_us&edition=fundamental","pubTime":"2026-09-15 15:19","pubTimestamp":1789456752,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Eli Lilly, McDonald's, WelltowerSept 15 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Eli Lilly, M","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4N4570I2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BKV","DT","PLAY","AAON","JAN","VSH","RBLX","ZBRA","NKE","DAVE","MCD","DFTX","RMD","SYM","VTR","IBP","MSTR","LIF","SMST","THO","LEA","WELL","ASTH","DOC","MIDD","SYK","BSX","HR","VC","LLY","PPL","RBLY","BWIN","SRRK","CAKE","NTSK","LYNX","USRT","RWR","AGL","CNP","ENVA","ULTA","THRM","RIVN","GLW","SPCX","RBLU","CRDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667662788","title":"Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS) and Cardiff Oncology (CRDF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667662788","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667662788?lang=en_us&edition=fundamental","pubTime":"2026-09-14 23:30","pubTimestamp":1789399820,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Addus Homecare (ADUS) and Cardiff Oncology (CRDF)....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-addus-homecare-adus-and-cardiff-oncology-crdf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-addus-homecare-adus-and-cardiff-oncology-crdf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRDF","LABU","IE00BN0W2T93.GBP","BK4137","LU0128526141.USD","ADUS","BK4581","XLV","BK4196","IE00BN0W2V16.EUR","BK4585","LU0029874061.USD","XBI","BK4139","HCSG","BK4588","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667697506","title":"Cardiff Oncology - no Admission of Liability or Monetary Payment in Cardiff-Nerviano Settlement - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2667697506","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667697506?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:29","pubTimestamp":1789392590,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nFWN4560JR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667666812","title":"Cardiff Oncology, Nerviano Settle Onvansertib Rights Lawsuit, Seek Dismissal with Prejudice","url":"https://stock-news.laohu8.com/highlight/detail?id=2667666812","media":"Reuters","labels":["corporation","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667666812?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:31","pubTimestamp":1789389064,"startTime":"0","endTime":"0","summary":"Cardiff Oncology, Nerviano settle onvansertib rights lawsuit, seek dismissal with prejudiceCardiff Oncology reached a settlement with Nerviano Medical Sciences tied to litigation over global rights to","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDLV93B4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BQXX3C00.GBP","BK4139","IE00BN0W2W23.USD","BK4112","BCDF","CRDF","IE00B3QW5Z07.USD","NDAQ","IE00BN0W2V16.EUR","SG9999014005.SGD","LU2210150020.SGD","LU0314104364.USD","SG9999014013.SGD","IE00BGHQF748.EUR","BK4588","LU2095319765.USD","IE00BN0W2T93.GBP","SG9999014039.USD","IE00BQXX3D17.EUR","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00BQXX3F31.USD","BK4585","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667666835","title":"Cardiff Oncology, - Co and Nms Agree to Full Mutual Release of All Claims in Litigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2667666835","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667666835?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:30","pubTimestamp":1789389000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUABGJQY1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667666572","title":"Cardiff Oncology and Nerviano Medical Sciences Amend Their 2017 Exclusive License Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2667666572","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667666572?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:30","pubTimestamp":1789389000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUABGJQY1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRDF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664181510","title":"Cardiff Oncology to Present at RAS-Targeted Drug Development Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2664181510","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664181510?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:02","pubTimestamp":1788346949,"startTime":"0","endTime":"0","summary":"Cardiff Oncology to present at RAS-targeted drug development summitCardiff Oncology will present at the 8th Annual RAS-Targeted Drug Development Summit on Sept. 8 at 9:00 a.m. ET.Mani Mohindru will jo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL8bcNWY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014021.USD","SG9999014005.SGD","BCDF","LU2210150020.SGD","SG9999014013.SGD","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","LU2210149790.SGD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BGHQF748.EUR","BK4112","NDAQ","IE00BQXX3C00.GBP","LU2095319765.USD","IE00BN0W2V16.EUR","BK4139","CRDF","BK4588","BK4585","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662741472","title":"Cardiff Oncology Announces Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2662741472","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662741472?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:01","pubTimestamp":1787774507,"startTime":"0","endTime":"0","summary":"Cardiff Oncology announces special shareholder meetingCardiff Oncology will hold a special stockholder meeting in San Diego on Oct. 22, 2026.Votes will be sought to raise authorized capital stock to 3","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL831C9B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRDF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659126232","title":"Cardiff Oncology Announces Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2659126232","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659126232?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:03","pubTimestamp":1786737807,"startTime":"0","endTime":"0","summary":"Cardiff Oncology announces special shareholder meetingCardiff Oncology plans a special stockholder meeting in San Diego in October 2026.Vote on amending the certificate of incorporation to raise autho","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL1K41xB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659149626","title":"Replimune Q1 Net Loss Narrows as Expenses Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2659149626","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659149626?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:14","pubTimestamp":1786709664,"startTime":"0","endTime":"0","summary":"Replimune Q1 net loss narrows as expenses declineOverviewUS oncolytic immunotherapy firm's fiscal Q1 net loss narrowed year-over-yearCompany received FDA accelerated approval for TUDRIQEV in advanced ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0EB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRDF","BK4563","BK4139","REPL","IMNM"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cardiffoncology.com","stockEarnings":[{"period":"1week","weight":-0.0353},{"period":"1month","weight":-0.3146},{"period":"3month","weight":0.1204},{"period":"6month","weight":-0.4541},{"period":"1year","weight":-0.5789},{"period":"ytd","weight":-0.6658}],"compareEarnings":[{"period":"1week","weight":0.0045},{"period":"1month","weight":-0.0005},{"period":"3month","weight":0.0473},{"period":"6month","weight":0.0829},{"period":"1year","weight":0.1516},{"period":"ytd","weight":0.1337}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies to treat various cancers in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor to treatment a range of solid tumor cancers and KRAS/NRAS-mutated metastatic colorectal and metastatic pancreatic cancer, as well as investigator-initiated trials in triple negative breast cancer and small cell lung cancer; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. The company primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.023989},{"month":2,"riseRate":0.5,"avgChangeRate":0.28397},{"month":3,"riseRate":0.357143,"avgChangeRate":0.075052},{"month":4,"riseRate":0.357143,"avgChangeRate":-0.062128},{"month":5,"riseRate":0.5,"avgChangeRate":0.055529},{"month":6,"riseRate":0.357143,"avgChangeRate":0.244554},{"month":7,"riseRate":0.4,"avgChangeRate":-0.096823},{"month":8,"riseRate":0.6,"avgChangeRate":0.104881},{"month":9,"riseRate":0.333333,"avgChangeRate":0.029652},{"month":10,"riseRate":0.466667,"avgChangeRate":-0.028803},{"month":11,"riseRate":0.357143,"avgChangeRate":0.032453},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.01141}],"exchange":"NASDAQ","name":"Cardiff Oncology, Inc.","nameEN":"Cardiff Oncology, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cardiff Oncology, Inc.(CRDF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Cardiff Oncology, Inc.(CRDF) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Cardiff Oncology, Inc.,CRDF,Cardiff Oncology, Inc.股票,Cardiff Oncology, Inc.股票老虎,Cardiff Oncology, Inc.股票老虎国际,Cardiff Oncology, Inc.行情,Cardiff Oncology, Inc.股票行情,Cardiff Oncology, Inc.股价,Cardiff Oncology, Inc.股市,Cardiff Oncology, Inc.股票价格,Cardiff Oncology, Inc.股票交易,Cardiff Oncology, Inc.股票购买,Cardiff Oncology, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cardiff Oncology, Inc.(CRDF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Cardiff Oncology, Inc.(CRDF) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction